BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Levenick JM, Andrews CL, Purich ED, Gordon SR, Gardner TB. A phase II trial of human secretin infusion for refractory type B pain in chronic pancreatitis. Pancreas. 2013;42:596-600. [PMID: 23548879 DOI: 10.1097/mpa.0b013e318273f3ec] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Jagannath S, Garg PK. Novel and Experimental Therapies in Chronic Pancreatitis. Dig Dis Sci 2017;62:1751-61. [PMID: 28551708 DOI: 10.1007/s10620-017-4604-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
2 . A Phase II Trial of Human Secretin Infusion for Refractory Type B Pain in Chronic Pancreatitis: Erratum. Pancreas 2016;45:e23. [PMID: 27077722 DOI: 10.1097/MPA.0000000000000664] [Reference Citation Analysis]
3 Olesen SS, Juel J, Graversen C, Kolesnikov Y, Wilder-Smith OH, Drewes AM. Pharmacological pain management in chronic pancreatitis. World J Gastroenterol 2013; 19(42): 7292-7301 [PMID: 24259960 DOI: 10.3748/wjg.v19.i42.7292] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
4 Talukdar R, Reddy DN. Pain in chronic pancreatitis: Managing beyond the pancreatic duct. World J Gastroenterol 2013; 19(38): 6319-6328 [PMID: 24151350 DOI: 10.3748/wjg.v19.i38.6319] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]